New & Notable

Understanding pharmaceutical patent thickets, exclusivity

Understanding pharmaceutical patent thickets, exclusivity

Pharmaceutical companies increasingly rely on dense patent thickets, including continuation patents, to delay competition, extend exclusivity and protect profits.

Novo Nordisk CEO steps down amid increased competition

Novo Nordisk CEO steps down amid increased competition

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down as the company faces heightened competition and a declining share price.

Systemic gaps hinder cell and gene therapy adoption, access

Systemic gaps hinder cell and gene therapy adoption, access

Over 200 cell and gene therapy treatments could be FDA-approved by 2030, but adoption could lag due to structural barriers, limited infrastructure and centralized access.

How digital twins are reshaping clinical trials

How digital twins are reshaping clinical trials

As drug development costs soar and timelines tighten, AI digital twins help sponsors cut enrollment, speed timelines and improve trial design, while meeting regulatory standards.

View All The Latest News

Insights

Insights is research conducted by and for TechTarget Xtelligent Healthcare. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.

Access All Reports

Healthcare Strategies: A Podcast

  • A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.

    Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.

    View All Episodes

Latest News

View All The Latest News

Features

View All Features